NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

2023398 citationsJournal Articlehybrid Open Access

Authors

For the plain language summary see Supplementary Materials section.

Good health and well-being

Published in: The Lancet

Volume 402, Issue 10409, pp. 1272-1281

Field-Weighted Citation Impact: 91.66